For research use only. Not for therapeutic Use.
CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1.7.
| Catalog Number | I020100 |
| CAS Number | 1884500-15-5 |
| Synonyms | N-(2-methoxyethyl)-3-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-2H-indazole-5-carboxamide |
| Molecular Formula | C22H23N5O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C22H23N5O2/c1-27-14-18(13-24-27)16-5-3-15(4-6-16)11-21-19-12-17(7-8-20(19)25-26-21)22(28)23-9-10-29-2/h3-8,12-14H,9-11H2,1-2H3,(H,23,28)(H,25,26) |
| InChIKey | MYODQBLYOKTZML-UHFFFAOYSA-N |
| SMILES | CN1C=C(C=N1)C2=CC=C(C=C2)CC3=C4C=C(C=CC4=NN3)C(=O)NCCOC |
| Reference | [1]. Kai S, et al. Preparation of substituted indazoles as CDK8 inhibitors for treatment of proliferative diseases. WO 2016041618 A1 20160324 |
